Roszczenko, P.; Holota, S.; Szewczyk, O.K.; Dudchak, R.; Bielawski, K.; Bielawska, A.; Lesyk, R.
4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design. Int. J. Mol. Sci. 2022, 23, 13135.
https://doi.org/10.3390/ijms232113135
AMA Style
Roszczenko P, Holota S, Szewczyk OK, Dudchak R, Bielawski K, Bielawska A, Lesyk R.
4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design. International Journal of Molecular Sciences. 2022; 23(21):13135.
https://doi.org/10.3390/ijms232113135
Chicago/Turabian Style
Roszczenko, Piotr, Serhii Holota, Olga Klaudia Szewczyk, Rostyslav Dudchak, Krzysztof Bielawski, Anna Bielawska, and Roman Lesyk.
2022. "4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design" International Journal of Molecular Sciences 23, no. 21: 13135.
https://doi.org/10.3390/ijms232113135
APA Style
Roszczenko, P., Holota, S., Szewczyk, O. K., Dudchak, R., Bielawski, K., Bielawska, A., & Lesyk, R.
(2022). 4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design. International Journal of Molecular Sciences, 23(21), 13135.
https://doi.org/10.3390/ijms232113135